img

Global Pulmonary Surfactant Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pulmonary Surfactant Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Pulmonary surfactant is a mixture of lipids and proteins which is secreted into the alveolar space by epithelial type II cells. The main function of surfactant is to lower the surface tension at the air/liquid interface within the alveoli of the lung.
Pulmonary Surfactant report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pulmonary Surfactant market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and laboratory are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pulmonary Surfactant industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pulmonary Surfactant key manufacturers include Boehringer Ingelheim, AbbVie, Lyomark Pharma, Tekzima (Noargen), ONY Biotech, Abbott, Aviva Systems Biology, LSBio and Biomatik, etc. Boehringer Ingelheim, AbbVie, Lyomark Pharma are top 3 players and held % sales share in total in 2022.
Pulmonary Surfactant can be divided into Synthetic Pulmonary Surfactants and Animal Derived Surfactants, etc. Synthetic Pulmonary Surfactants is the mainstream product in the market, accounting for % sales share globally in 2022.
Pulmonary Surfactant is widely used in various fields, such as Hospital, laboratory and Others,, etc. Hospital provides greatest supports to the Pulmonary Surfactant industry development. In 2022, global % sales of Pulmonary Surfactant went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pulmonary Surfactant market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Boehringer Ingelheim
AbbVie
Lyomark Pharma
Tekzima (Noargen)
ONY Biotech
Abbott
Aviva Systems Biology
LSBio
Biomatik
Biorbyt
Reddot Biotech
XpressBio
Creative Diagnostics
Nanjing Norris Pharm Technology
Windtree Therapeutics
Segment by Type
Synthetic Pulmonary Surfactants
Animal Derived Surfactants

Segment by Application


Hospital
laboratory
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pulmonary Surfactant market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pulmonary Surfactant, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pulmonary Surfactant industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Pulmonary Surfactant in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pulmonary Surfactant introduction, etc. Pulmonary Surfactant Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Pulmonary Surfactant market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Pulmonary Surfactant Market Overview
1.1 Pulmonary Surfactant Product Overview
1.2 Pulmonary Surfactant Market Segment by Type
1.2.1 Synthetic Pulmonary Surfactants
1.2.2 Animal Derived Surfactants
1.3 Global Pulmonary Surfactant Market Size by Type
1.3.1 Global Pulmonary Surfactant Market Size Overview by Type (2024-2034)
1.3.2 Global Pulmonary Surfactant Historic Market Size Review by Type (2024-2024)
1.3.3 Global Pulmonary Surfactant Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pulmonary Surfactant Sales Breakdown by Type (2024-2024)
1.4.2 Europe Pulmonary Surfactant Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Pulmonary Surfactant Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Pulmonary Surfactant Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Pulmonary Surfactant Sales Breakdown by Type (2024-2024)
2 Global Pulmonary Surfactant Market Competition by Company
2.1 Global Top Players by Pulmonary Surfactant Sales (2024-2024)
2.2 Global Top Players by Pulmonary Surfactant Revenue (2024-2024)
2.3 Global Top Players by Pulmonary Surfactant Price (2024-2024)
2.4 Global Top Manufacturers Pulmonary Surfactant Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pulmonary Surfactant Market Competitive Situation and Trends
2.5.1 Pulmonary Surfactant Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Pulmonary Surfactant Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pulmonary Surfactant as of 2022)
2.7 Date of Key Manufacturers Enter into Pulmonary Surfactant Market
2.8 Key Manufacturers Pulmonary Surfactant Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pulmonary Surfactant Status and Outlook by Region
3.1 Global Pulmonary Surfactant Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Pulmonary Surfactant Historic Market Size by Region
3.2.1 Global Pulmonary Surfactant Sales in Volume by Region (2024-2024)
3.2.2 Global Pulmonary Surfactant Sales in Value by Region (2024-2024)
3.2.3 Global Pulmonary Surfactant Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Pulmonary Surfactant Forecasted Market Size by Region
3.3.1 Global Pulmonary Surfactant Sales in Volume by Region (2024-2034)
3.3.2 Global Pulmonary Surfactant Sales in Value by Region (2024-2034)
3.3.3 Global Pulmonary Surfactant Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Pulmonary Surfactant by Application
4.1 Pulmonary Surfactant Market Segment by Application
4.1.1 Hospital
4.1.2 laboratory
4.1.3 Others
4.2 Global Pulmonary Surfactant Market Size by Application
4.2.1 Global Pulmonary Surfactant Market Size Overview by Application (2024-2034)
4.2.2 Global Pulmonary Surfactant Historic Market Size Review by Application (2024-2024)
4.2.3 Global Pulmonary Surfactant Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pulmonary Surfactant Sales Breakdown by Application (2024-2024)
4.3.2 Europe Pulmonary Surfactant Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Pulmonary Surfactant Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Pulmonary Surfactant Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Pulmonary Surfactant Sales Breakdown by Application (2024-2024)
5 North America Pulmonary Surfactant by Country
5.1 North America Pulmonary Surfactant Historic Market Size by Country
5.1.1 North America Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Pulmonary Surfactant Sales in Volume by Country (2024-2024)
5.1.3 North America Pulmonary Surfactant Sales in Value by Country (2024-2024)
5.2 North America Pulmonary Surfactant Forecasted Market Size by Country
5.2.1 North America Pulmonary Surfactant Sales in Volume by Country (2024-2034)
5.2.2 North America Pulmonary Surfactant Sales in Value by Country (2024-2034)
6 Europe Pulmonary Surfactant by Country
6.1 Europe Pulmonary Surfactant Historic Market Size by Country
6.1.1 Europe Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Pulmonary Surfactant Sales in Volume by Country (2024-2024)
6.1.3 Europe Pulmonary Surfactant Sales in Value by Country (2024-2024)
6.2 Europe Pulmonary Surfactant Forecasted Market Size by Country
6.2.1 Europe Pulmonary Surfactant Sales in Volume by Country (2024-2034)
6.2.2 Europe Pulmonary Surfactant Sales in Value by Country (2024-2034)
7 Asia-Pacific Pulmonary Surfactant by Region
7.1 Asia-Pacific Pulmonary Surfactant Historic Market Size by Region
7.1.1 Asia-Pacific Pulmonary Surfactant Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Pulmonary Surfactant Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Pulmonary Surfactant Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Pulmonary Surfactant Forecasted Market Size by Region
7.2.1 Asia-Pacific Pulmonary Surfactant Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Pulmonary Surfactant Sales in Value by Region (2024-2034)
8 Latin America Pulmonary Surfactant by Country
8.1 Latin America Pulmonary Surfactant Historic Market Size by Country
8.1.1 Latin America Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Pulmonary Surfactant Sales in Volume by Country (2024-2024)
8.1.3 Latin America Pulmonary Surfactant Sales in Value by Country (2024-2024)
8.2 Latin America Pulmonary Surfactant Forecasted Market Size by Country
8.2.1 Latin America Pulmonary Surfactant Sales in Volume by Country (2024-2034)
8.2.2 Latin America Pulmonary Surfactant Sales in Value by Country (2024-2034)
9 Middle East and Africa Pulmonary Surfactant by Country
9.1 Middle East and Africa Pulmonary Surfactant Historic Market Size by Country
9.1.1 Middle East and Africa Pulmonary Surfactant Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Pulmonary Surfactant Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Pulmonary Surfactant Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Pulmonary Surfactant Forecasted Market Size by Country
9.2.1 Middle East and Africa Pulmonary Surfactant Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Pulmonary Surfactant Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Boehringer Ingelheim
10.1.1 Boehringer Ingelheim Company Information
10.1.2 Boehringer Ingelheim Introduction and Business Overview
10.1.3 Boehringer Ingelheim Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Boehringer Ingelheim Pulmonary Surfactant Products Offered
10.1.5 Boehringer Ingelheim Recent Development
10.2 AbbVie
10.2.1 AbbVie Company Information
10.2.2 AbbVie Introduction and Business Overview
10.2.3 AbbVie Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.2.4 AbbVie Pulmonary Surfactant Products Offered
10.2.5 AbbVie Recent Development
10.3 Lyomark Pharma
10.3.1 Lyomark Pharma Company Information
10.3.2 Lyomark Pharma Introduction and Business Overview
10.3.3 Lyomark Pharma Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Lyomark Pharma Pulmonary Surfactant Products Offered
10.3.5 Lyomark Pharma Recent Development
10.4 Tekzima (Noargen)
10.4.1 Tekzima (Noargen) Company Information
10.4.2 Tekzima (Noargen) Introduction and Business Overview
10.4.3 Tekzima (Noargen) Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Tekzima (Noargen) Pulmonary Surfactant Products Offered
10.4.5 Tekzima (Noargen) Recent Development
10.5 ONY Biotech
10.5.1 ONY Biotech Company Information
10.5.2 ONY Biotech Introduction and Business Overview
10.5.3 ONY Biotech Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.5.4 ONY Biotech Pulmonary Surfactant Products Offered
10.5.5 ONY Biotech Recent Development
10.6 Abbott
10.6.1 Abbott Company Information
10.6.2 Abbott Introduction and Business Overview
10.6.3 Abbott Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Abbott Pulmonary Surfactant Products Offered
10.6.5 Abbott Recent Development
10.7 Aviva Systems Biology
10.7.1 Aviva Systems Biology Company Information
10.7.2 Aviva Systems Biology Introduction and Business Overview
10.7.3 Aviva Systems Biology Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Aviva Systems Biology Pulmonary Surfactant Products Offered
10.7.5 Aviva Systems Biology Recent Development
10.8 LSBio
10.8.1 LSBio Company Information
10.8.2 LSBio Introduction and Business Overview
10.8.3 LSBio Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.8.4 LSBio Pulmonary Surfactant Products Offered
10.8.5 LSBio Recent Development
10.9 Biomatik
10.9.1 Biomatik Company Information
10.9.2 Biomatik Introduction and Business Overview
10.9.3 Biomatik Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Biomatik Pulmonary Surfactant Products Offered
10.9.5 Biomatik Recent Development
10.10 Biorbyt
10.10.1 Biorbyt Company Information
10.10.2 Biorbyt Introduction and Business Overview
10.10.3 Biorbyt Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Biorbyt Pulmonary Surfactant Products Offered
10.10.5 Biorbyt Recent Development
10.11 Reddot Biotech
10.11.1 Reddot Biotech Company Information
10.11.2 Reddot Biotech Introduction and Business Overview
10.11.3 Reddot Biotech Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Reddot Biotech Pulmonary Surfactant Products Offered
10.11.5 Reddot Biotech Recent Development
10.12 XpressBio
10.12.1 XpressBio Company Information
10.12.2 XpressBio Introduction and Business Overview
10.12.3 XpressBio Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.12.4 XpressBio Pulmonary Surfactant Products Offered
10.12.5 XpressBio Recent Development
10.13 Creative Diagnostics
10.13.1 Creative Diagnostics Company Information
10.13.2 Creative Diagnostics Introduction and Business Overview
10.13.3 Creative Diagnostics Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Creative Diagnostics Pulmonary Surfactant Products Offered
10.13.5 Creative Diagnostics Recent Development
10.14 Nanjing Norris Pharm Technology
10.14.1 Nanjing Norris Pharm Technology Company Information
10.14.2 Nanjing Norris Pharm Technology Introduction and Business Overview
10.14.3 Nanjing Norris Pharm Technology Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.14.4 Nanjing Norris Pharm Technology Pulmonary Surfactant Products Offered
10.14.5 Nanjing Norris Pharm Technology Recent Development
10.15 Windtree Therapeutics
10.15.1 Windtree Therapeutics Company Information
10.15.2 Windtree Therapeutics Introduction and Business Overview
10.15.3 Windtree Therapeutics Pulmonary Surfactant Sales, Revenue and Gross Margin (2024-2024)
10.15.4 Windtree Therapeutics Pulmonary Surfactant Products Offered
10.15.5 Windtree Therapeutics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pulmonary Surfactant Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pulmonary Surfactant Industrial Chain Analysis
11.4 Pulmonary Surfactant Market Dynamics
11.4.1 Pulmonary Surfactant Industry Trends
11.4.2 Pulmonary Surfactant Market Drivers
11.4.3 Pulmonary Surfactant Market Challenges
11.4.4 Pulmonary Surfactant Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pulmonary Surfactant Distributors
12.3 Pulmonary Surfactant Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Synthetic Pulmonary Surfactants
Table 2. Major Company of Animal Derived Surfactants
Table 3. Global Pulmonary Surfactant Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Pulmonary Surfactant Sales by Type (2024-2024) & (K Units)
Table 5. Global Pulmonary Surfactant Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Pulmonary Surfactant Sales by Type (2024-2024) & (US& Million)
Table 7. Global Pulmonary Surfactant Market Share in Value by Type (2024-2024)
Table 8. Global Pulmonary Surfactant Price by Type (2024-2024) & (USD/Unit)
Table 9. Global Pulmonary Surfactant Sales by Type (2024-2034) & (K Units)
Table 10. Global Pulmonary Surfactant Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Pulmonary Surfactant Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Pulmonary Surfactant Sales Market Share in Value by Type (2024-2034)
Table 13. Global Pulmonary Surfactant Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Pulmonary Surfactant Sales by Type (2024-2024) & (K Units)
Table 15. North America Pulmonary Surfactant Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Pulmonary Surfactant Sales (K Units) by Type (2024-2024)
Table 17. Europe Pulmonary Surfactant Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Pulmonary Surfactant Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Pulmonary Surfactant Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Pulmonary Surfactant Sales (K Units) by Type (2024-2024)
Table 21. Latin America Pulmonary Surfactant Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Pulmonary Surfactant Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Pulmonary Surfactant Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Pulmonary Surfactant Sales by Company (2024-2024) & (K Units)
Table 25. Global Pulmonary Surfactant Sales Share by Company (2024-2024)
Table 26. Global Pulmonary Surfactant Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Pulmonary Surfactant Revenue Share by Company (2024-2024)
Table 28. Global Market Pulmonary Surfactant Price by Company (2024-2024) & (USD/Unit)
Table 29. Global Pulmonary Surfactant Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Pulmonary Surfactant Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pulmonary Surfactant as of 2022)
Table 32. Date of Key Manufacturers Enter into Pulmonary Surfactant Market
Table 33. Key Manufacturers Pulmonary Surfactant Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Pulmonary Surfactant Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Pulmonary Surfactant Sales by Region (2024-2024) & (K Units)
Table 37. Global Pulmonary Surfactant Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Pulmonary Surfactant Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Pulmonary Surfactant Sales Market Share in Value by Region (2024-2024)
Table 40. Global Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 41. Global Pulmonary Surfactant Sales by Region (2024-2034) & (K Units)
Table 42. Global Pulmonary Surfactant Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Pulmonary Surfactant Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Pulmonary Surfactant Sales Market Share in Value by Region (2024-2034)
Table 45. Global Pulmonary Surfactant Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Pulmonary Surfactant Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Pulmonary Surfactant Sales by Application (2024-2024) & (K Units)
Table 48. Global Pulmonary Surfactant Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Pulmonary Surfactant Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Pulmonary Surfactant Sales Market Share in Value by Application (2024-2024)
Table 51. Global Pulmonary Surfactant Price by Application (2024-2024) & (USD/Unit)
Table 52. Global Pulmonary Surfactant Sales by Application (2024-2034) & (K Units)
Table 53. Global Pulmonary Surfactant Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Pulmonary Surfactant Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Pulmonary Surfactant Sales Market Share in Value by Application (2024-2034)
Table 56. Global Pulmonary Surfactant Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Pulmonary Surfactant Sales by Application (2024-2024) (K Units)
Table 58. North America Pulmonary Surfactant Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Pulmonary Surfactant Sales by Application (2024-2024) (K Units)
Table 60. Europe Pulmonary Surfactant Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Pulmonary Surfactant Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Pulmonary Surfactant Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Pulmonary Surfactant Sales by Application (2024-2024) (K Units)
Table 64. Latin America Pulmonary Surfactant Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Pulmonary Surfactant Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Pulmonary Surfactant Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Pulmonary Surfactant Sales by Country (2024-2024) & (K Units)
Table 68. North America Pulmonary Surfactant Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Pulmonary Surfactant Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Pulmonary Surfactant Sales Market Share in Value by Country (2024-2024)
Table 71. North America Pulmonary Surfactant Sales by Country (2024-2034) & (K Units)
Table 72. North America Pulmonary Surfactant Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Pulmonary Surfactant Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Pulmonary Surfactant Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Pulmonary Surfactant Sales by Country (2024-2024) & (K Units)
Table 76. Europe Pulmonary Surfactant Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Pulmonary Surfactant Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Pulmonary Surfactant Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Pulmonary Surfactant Sales by Country (2024-2034) & (K Units)
Table 80. Europe Pulmonary Surfactant Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Pulmonary Surfactant Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Pulmonary Surfactant Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Pulmonary Surfactant Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Pulmonary Surfactant Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Pulmonary Surfactant Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Pulmonary Surfactant Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Pulmonary Surfactant Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Pulmonary Surfactant Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Pulmonary Surfactant Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Pulmonary Surfactant Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Pulmonary Surfactant Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Pulmonary Surfactant Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Pulmonary Surfactant Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Pulmonary Surfactant Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Pulmonary Surfactant Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Pulmonary Surfactant Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Pulmonary Surfactant Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Pulmonary Surfactant Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Pulmonary Surfactant Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Pulmonary Surfactant Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Pulmonary Surfactant Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Pulmonary Surfactant Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Pulmonary Surfactant Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Pulmonary Surfactant Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Pulmonary Surfactant Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Pulmonary Surfactant Sales Market Share in Value by Country (2024-2034)
Table 107. Boehringer Ingelheim Company Information
Table 108. Boehringer Ingelheim Introduction and Business Overview
Table 109. Boehringer Ingelheim Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 110. Boehringer Ingelheim Pulmonary Surfactant Product
Table 111. Boehringer Ingelheim Recent Development
Table 112. AbbVie Company Information
Table 113. AbbVie Introduction and Business Overview
Table 114. AbbVie Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 115. AbbVie Pulmonary Surfactant Product
Table 116. AbbVie Recent Development
Table 117. Lyomark Pharma Company Information
Table 118. Lyomark Pharma Introduction and Business Overview
Table 119. Lyomark Pharma Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 120. Lyomark Pharma Pulmonary Surfactant Product
Table 121. Lyomark Pharma Recent Development
Table 122. Tekzima (Noargen) Company Information
Table 123. Tekzima (Noargen) Introduction and Business Overview
Table 124. Tekzima (Noargen) Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 125. Tekzima (Noargen) Pulmonary Surfactant Product
Table 126. Tekzima (Noargen) Recent Development
Table 127. ONY Biotech Company Information
Table 128. ONY Biotech Introduction and Business Overview
Table 129. ONY Biotech Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 130. ONY Biotech Pulmonary Surfactant Product
Table 131. ONY Biotech Recent Development
Table 132. Abbott Company Information
Table 133. Abbott Introduction and Business Overview
Table 134. Abbott Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 135. Abbott Pulmonary Surfactant Product
Table 136. Abbott Recent Development
Table 137. Aviva Systems Biology Company Information
Table 138. Aviva Systems Biology Introduction and Business Overview
Table 139. Aviva Systems Biology Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 140. Aviva Systems Biology Pulmonary Surfactant Product
Table 141. Aviva Systems Biology Recent Development
Table 142. LSBio Company Information
Table 143. LSBio Introduction and Business Overview
Table 144. LSBio Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 145. LSBio Pulmonary Surfactant Product
Table 146. LSBio Recent Development
Table 147. Biomatik Company Information
Table 148. Biomatik Introduction and Business Overview
Table 149. Biomatik Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 150. Biomatik Pulmonary Surfactant Product
Table 151. Biomatik Recent Development
Table 152. Biorbyt Company Information
Table 153. Biorbyt Introduction and Business Overview
Table 154. Biorbyt Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 155. Biorbyt Pulmonary Surfactant Product
Table 156. Biorbyt Recent Development
Table 157. Reddot Biotech Company Information
Table 158. Reddot Biotech Introduction and Business Overview
Table 159. Reddot Biotech Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 160. Reddot Biotech Pulmonary Surfactant Product
Table 161. Reddot Biotech Recent Development
Table 162. XpressBio Company Information
Table 163. XpressBio Introduction and Business Overview
Table 164. XpressBio Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 165. XpressBio Pulmonary Surfactant Product
Table 166. XpressBio Recent Development
Table 167. Creative Diagnostics Company Information
Table 168. Creative Diagnostics Introduction and Business Overview
Table 169. Creative Diagnostics Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 170. Creative Diagnostics Pulmonary Surfactant Product
Table 171. Creative Diagnostics Recent Development
Table 172. Nanjing Norris Pharm Technology Company Information
Table 173. Nanjing Norris Pharm Technology Introduction and Business Overview
Table 174. Nanjing Norris Pharm Technology Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 175. Nanjing Norris Pharm Technology Pulmonary Surfactant Product
Table 176. Nanjing Norris Pharm Technology Recent Development
Table 177. Windtree Therapeutics Company Information
Table 178. Windtree Therapeutics Introduction and Business Overview
Table 179. Windtree Therapeutics Pulmonary Surfactant Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 180. Windtree Therapeutics Pulmonary Surfactant Product
Table 181. Windtree Therapeutics Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Pulmonary Surfactant Market Trends
Table 185. Pulmonary Surfactant Market Drivers
Table 186. Pulmonary Surfactant Market Challenges
Table 187. Pulmonary Surfactant Market Restraints
Table 188. Pulmonary Surfactant Distributors List
Table 189. Pulmonary Surfactant Downstream Customers
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Pulmonary Surfactant Product Picture
Figure 2. Global Pulmonary Surfactant Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Pulmonary Surfactant Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Pulmonary Surfactant Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Synthetic Pulmonary Surfactants
Figure 6. Global Synthetic Pulmonary Surfactants Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Animal Derived Surfactants
Figure 8. Global Animal Derived Surfactants Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Pulmonary Surfactant Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Pulmonary Surfactant Sales Market Share by Type in 2022 & 2034
Figure 11. North America Pulmonary Surfactant Sales Market Share in Volume by Type in 2022
Figure 12. North America Pulmonary Surfactant Sales Market Share in Value by Type in 2022
Figure 13. Europe Pulmonary Surfactant Sales Market Share in Volume by Type in 2022
Figure 14. Europe Pulmonary Surfactant Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Pulmonary Surfactant Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Pulmonary Surfactant Sales Market Share in Value by Type in 2022
Figure 17. Latin America Pulmonary Surfactant Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Pulmonary Surfactant Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Pulmonary Surfactant Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Pulmonary Surfactant Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Pulmonary Surfactant Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Pulmonary Surfactant Revenue in 2022
Figure 23. Pulmonary Surfactant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of laboratory
Figure 27. Global laboratory Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Pulmonary Surfactant Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Pulmonary Surfactant Sales Market Share by Application in 2022 & 2034
Figure 32. North America Pulmonary Surfactant Sales Market Share in Volume by Application in 2022
Figure 33. North America Pulmonary Surfactant Sales Market Share in Value by Application in 2022
Figure 34. Europe Pulmonary Surfactant Sales Market Share in Volume by Application in 2022
Figure 35. Europe Pulmonary Surfactant Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Pulmonary Surfactant Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Pulmonary Surfactant Sales Market Share in Value by Application in 2022
Figure 38. Latin America Pulmonary Surfactant Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Pulmonary Surfactant Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Pulmonary Surfactant Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Pulmonary Surfactant Manufacturing Cost Structure
Figure 43. Pulmonary Surfactant Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries